메뉴 건너뛰기




Volumn 65, Issue 6, 2014, Pages 1184-1190

A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml

Author keywords

Cancer; Genetic risk; Prostate; PSA; Risk stratification; SNP

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 84899572840     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.07.005     Document Type: Article
Times cited : (34)

References (32)
  • 1
    • 0023233060 scopus 로고
    • Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
    • T.A. Stamey, N. Yang, A.R. Hay, J.E. McNeal, F.S. Freiha, and E. Redwine Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909 916
    • (1987) N Engl J Med , vol.317 , pp. 909-916
    • Stamey, T.A.1    Yang, N.2    Hay, A.R.3    McNeal, J.E.4    Freiha, F.S.5    Redwine, E.6
  • 2
    • 0029799835 scopus 로고    scopus 로고
    • Predictive properties of serum-prostate-specific antigen testing in a community-based setting
    • S.J. Jacobsen, E.J. Bergstralh, and H.A. Guess et al. Predictive properties of serum-prostate-specific antigen testing in a community-based setting Arch Intern Med 156 1996 2462 2468
    • (1996) Arch Intern Med , vol.156 , pp. 2462-2468
    • Jacobsen, S.J.1    Bergstralh, E.J.2    Guess, H.A.3
  • 4
    • 21444447966 scopus 로고    scopus 로고
    • Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower
    • I.M. Thompson, D.P. Ankerst, and C. Chi et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower JAMA 294 2005 66 70
    • (2005) JAMA , vol.294 , pp. 66-70
    • Thompson, I.M.1    Ankerst, D.P.2    Chi, C.3
  • 5
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level
    • I.M. Thompson, D.K. Pauler, and P.J. Goodman et al. Prevalence of prostate cancer among men with a prostate-specific antigen level N Engl J Med 350 2004 2239 2246
    • (2004) N Engl J Med , vol.350 , pp. 2239-2246
    • Thompson, I.M.1    Pauler, D.K.2    Goodman, P.J.3
  • 7
    • 78649362120 scopus 로고    scopus 로고
    • EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease
    • A. Heidenreich, J. Bellmunt, and M. Bolla et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
    • (2011) Eur Urol , vol.59 , pp. 61-71
    • Heidenreich, A.1    Bellmunt, J.2    Bolla, M.3
  • 8
    • 0034644185 scopus 로고    scopus 로고
    • Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland
    • P. Lichtenstein, N.V. Holm, and P.K. Verkasalo et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2000 78 85
    • (2000) N Engl J Med , vol.343 , pp. 78-85
    • Lichtenstein, P.1    Holm, N.V.2    Verkasalo, P.K.3
  • 9
    • 84868599480 scopus 로고    scopus 로고
    • Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: Findings from the REDUCE trial
    • A.K. Kader, J. Sun, and B.H. Reck et al. Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial Eur Urol 62 2012 953 961
    • (2012) Eur Urol , vol.62 , pp. 953-961
    • Kader, A.K.1    Sun, J.2    Reck, B.H.3
  • 10
    • 84856380174 scopus 로고    scopus 로고
    • Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men
    • R.J. Klein, C. Hallden, and A. Gupta et al. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men Eur Urol 61 2012 471 477
    • (2012) Eur Urol , vol.61 , pp. 471-477
    • Klein, R.J.1    Hallden, C.2    Gupta, A.3
  • 11
    • 84872931195 scopus 로고    scopus 로고
    • Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: Results from a population-based study, 2003-2011
    • T. Nordström, M. Aly, M.S. Clements, C.E. Weibull, J. Adolfsson, and H. Grönberg Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: results from a population-based study, 2003-2011 Eur Urol 63 2013 419 425
    • (2013) Eur Urol , vol.63 , pp. 419-425
    • Nordström, T.1    Aly, M.2    Clements, M.S.3    Weibull, C.E.4    Adolfsson, J.5    Grönberg, H.6
  • 12
    • 79957946061 scopus 로고    scopus 로고
    • Polygenic risk score improves prostate cancer risk prediction: Results from the Stockholm-1 cohort study
    • M. Aly, F. Wiklund, and J. Xu et al. Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study Eur Urol 60 2011 21 28
    • (2011) Eur Urol , vol.60 , pp. 21-28
    • Aly, M.1    Wiklund, F.2    Xu, J.3
  • 13
    • 24144493035 scopus 로고    scopus 로고
    • The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
    • J.I. Epstein, W.C.J. Allsbrook, M.B. Amin, and L.L. Egevad The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
    • (2005) Am J Surg Pathol , vol.29 , pp. 1228-1242
    • Epstein, J.I.1    Allsbrook, W.C.J.2    Amin, M.B.3    Egevad, L.L.4
  • 14
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    • discussion 207-12
    • M.J. Pencina, R.B.S. D'Agostino, R.B.J. D'Agostino, and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-12
    • (2008) Stat Med , vol.27 , pp. 157-172
    • Pencina, M.J.1    D'Agostino, R.B.S.2    D'Agostino, R.B.J.3    Vasan, R.S.4
  • 15
    • 63449085837 scopus 로고    scopus 로고
    • Utility of incorporating genetic variants for the early detection of prostate cancer
    • R.K. Nam, W.W. Zhang, and J. Trachtenberg et al. Utility of incorporating genetic variants for the early detection of prostate cancer Clin Cancer Res 15 2009 1787 1793
    • (2009) Clin Cancer Res , vol.15 , pp. 1787-1793
    • Nam, R.K.1    Zhang, W.W.2    Trachtenberg, J.3
  • 16
    • 84856380113 scopus 로고    scopus 로고
    • Prediction of prostate cancer risk: The role of prostate volume and digital rectal examination in the ERSPC risk calculators
    • M.J. Roobol, H.A. van Vugt, and S. Loeb et al. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators Eur Urol 61 2012 577 583
    • (2012) Eur Urol , vol.61 , pp. 577-583
    • Roobol, M.J.1    Van Vugt, H.A.2    Loeb, S.3
  • 17
    • 79960924160 scopus 로고    scopus 로고
    • Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
    • Z. Kote-Jarai, A.A. Olama Al, and G.G. Giles et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study Nat Genet 43 2011 785 791
    • (2011) Nat Genet , vol.43 , pp. 785-791
    • Kote-Jarai, Z.1    Olama Al, A.A.2    Giles, G.G.3
  • 18
    • 39749159112 scopus 로고    scopus 로고
    • Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
    • J. Gudmundsson, P. Sulem, and T. Rafnar et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer Nat Genet 40 2008 281 283
    • (2008) Nat Genet , vol.40 , pp. 281-283
    • Gudmundsson, J.1    Sulem, P.2    Rafnar, T.3
  • 19
    • 70349545839 scopus 로고    scopus 로고
    • Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
    • R.A. Eeles, Z. Kote-Jarai, and A.A. Olama Al et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study Nat Genet 41 2009 1116 1121
    • (2009) Nat Genet , vol.41 , pp. 1116-1121
    • Eeles, R.A.1    Kote-Jarai, Z.2    Olama Al, A.A.3
  • 20
    • 77956637724 scopus 로고    scopus 로고
    • Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
    • R. Takata, S. Akamatsu, and M. Kubo et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population Nat Genet 42 2010 751 754
    • (2010) Nat Genet , vol.42 , pp. 751-754
    • Takata, R.1    Akamatsu, S.2    Kubo, M.3
  • 21
    • 80052716147 scopus 로고    scopus 로고
    • Genome-wide association study identifies new prostate cancer susceptibility loci
    • F.R. Schumacher, S.I. Berndt, and A. Siddiq et al. Genome-wide association study identifies new prostate cancer susceptibility loci Hum Mol Genet 20 2011 3867 3875
    • (2011) Hum Mol Genet , vol.20 , pp. 3867-3875
    • Schumacher, F.R.1    Berndt, S.I.2    Siddiq, A.3
  • 22
    • 70349547128 scopus 로고    scopus 로고
    • Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
    • J. Gudmundsson, P. Sulem, and D.F. Gudbjartsson et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility Nat Genet 41 2009 1122 1126
    • (2009) Nat Genet , vol.41 , pp. 1122-1126
    • Gudmundsson, J.1    Sulem, P.2    Gudbjartsson, D.F.3
  • 23
    • 39749129053 scopus 로고    scopus 로고
    • Multiple newly identified loci associated with prostate cancer susceptibility
    • R.A. Eeles, Z. Kote-Jarai, and G.G. Giles et al. Multiple newly identified loci associated with prostate cancer susceptibility Nat Genet 40 2008 316 321
    • (2008) Nat Genet , vol.40 , pp. 316-321
    • Eeles, R.A.1    Kote-Jarai, Z.2    Giles, G.G.3
  • 24
    • 39749118602 scopus 로고    scopus 로고
    • Multiple loci identified in a genome-wide association study of prostate cancer
    • G. Thomas, K.B. Jacobs, and M. Yeager et al. Multiple loci identified in a genome-wide association study of prostate cancer Nat Genet 40 2008 310 315
    • (2008) Nat Genet , vol.40 , pp. 310-315
    • Thomas, G.1    Jacobs, K.B.2    Yeager, M.3
  • 25
    • 33745169697 scopus 로고    scopus 로고
    • A common variant associated with prostate cancer in European and African populations
    • L.T. Amundadottir, P. Sulem, and J. Gudmundsson et al. A common variant associated with prostate cancer in European and African populations Nat Genet 38 2006 652 658
    • (2006) Nat Genet , vol.38 , pp. 652-658
    • Amundadottir, L.T.1    Sulem, P.2    Gudmundsson, J.3
  • 26
    • 70349548806 scopus 로고    scopus 로고
    • Multiple loci on 8q24 associated with prostate cancer susceptibility
    • A.A. Olama Al, Z. Kote-Jarai, and G.G. Giles et al. Multiple loci on 8q24 associated with prostate cancer susceptibility Nat Genet 41 2009 1058 1060
    • (2009) Nat Genet , vol.41 , pp. 1058-1060
    • Olama Al, A.A.1    Kote-Jarai, Z.2    Giles, G.G.3
  • 27
    • 34247563453 scopus 로고    scopus 로고
    • Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
    • J. Gudmundsson, P. Sulem, and A. Manolescu et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 Nat Genet 39 2007 631 637
    • (2007) Nat Genet , vol.39 , pp. 631-637
    • Gudmundsson, J.1    Sulem, P.2    Manolescu, A.3
  • 28
  • 29
    • 34547510624 scopus 로고    scopus 로고
    • Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
    • J. Gudmundsson, P. Sulem, and V. Steinthorsdottir et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Nat Genet 39 2007 977 983
    • (2007) Nat Genet , vol.39 , pp. 977-983
    • Gudmundsson, J.1    Sulem, P.2    Steinthorsdottir, V.3
  • 30
    • 52949115663 scopus 로고    scopus 로고
    • Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12
    • J. Sun, S.L. Zheng, and F. Wiklund et al. Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12 Nat Genet 40 2008 1153 1155
    • (2008) Nat Genet , vol.40 , pp. 1153-1155
    • Sun, J.1    Zheng, S.L.2    Wiklund, F.3
  • 31
    • 79959731094 scopus 로고    scopus 로고
    • Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript
    • Z. Kote-Jarai, A. Amin Al Olama, and D. Leongamornlert et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript Hum Genet 129 2011 687 694
    • (2011) Hum Genet , vol.129 , pp. 687-694
    • Kote-Jarai, Z.1    Amin Al Olama, A.2    Leongamornlert, D.3
  • 32
    • 58249121582 scopus 로고    scopus 로고
    • Sequence variants at 22q13 are associated with prostate cancer risk
    • J. Sun, S.L. Zheng, and F. Wiklund et al. Sequence variants at 22q13 are associated with prostate cancer risk Cancer Res 69 2009 10 15
    • (2009) Cancer Res , vol.69 , pp. 10-15
    • Sun, J.1    Zheng, S.L.2    Wiklund, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.